XML 43 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Cash flows from operating activities    
Net loss $ (24,955) $ (12,825)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 5,875 5,609
Deferred income taxes 317 271
Bad debt expense and other reserves 109 153
Stock-based compensation 11,540 3,616
Increase in fair value of contingent consideration liability   48
Common stock warrant expense 4,668 1,262
Imputed interest on notes receivable 10 62
Interest income on notes receivable (18) (100)
Interest expense on note payable   805
Accretion of beneficial conversion feature on convertible notes payable and discount on revolving line of credit 236 945
Loss on disposal of fixed assets 211 325
Changes in operating assets and liabilities    
Accounts receivable (6,183) (4,317)
Prepaid expenses (3,319) (2,953)
Other current assets 457 (203)
Other assets (62) (30)
Accounts payable 491 (1,315)
Accrued employee expenses (410) 2,521
Other accrued expenses 4,700 178
Other liabilities (97) (175)
Net cash used in operating activities (6,430) (6,123)
Cash flows from investing activities    
Change in restricted cash   2,500
Purchase of property and equipment (4,790) (3,320)
Purchase of intangible assets (350)  
Notes receivable from related parties (60)  
Repayment of notes receivable from related parties 3,761  
Net cash used in investing activities (1,439) (820)
Cash flows from financing activities    
Proceeds from initial public offering, net of underwriting discounts 69,674  
Repayments under credit agreement (5,000)  
Repurchase of vested common stock option awards   (2,000)
Proceeds from exercise of common stock options 1,760 185
Exercise of warrants 9,461  
Net cash provided by (used in) financing activities 75,895 (1,815)
Net increase (decrease) in cash and cash equivalents 68,026 (8,758)
Cash and cash equivalents at beginning of period 43,819 22,062
Cash and cash equivalents at end of period 111,845 13,304
Supplemental disclosures of non-cash activities    
Stock-based compensation capitalized for software development 614 251
Capitalized assets included in accounts payable, accrued employee expenses and other accrued expenses 370 53
Conversion of convertible note payable and accrued interest to common stock   $ 25,447